Trials / Completed
CompletedNCT06730620
Bioequivalence Study of Methacholine Chloride
Bioequivalence Study of Methacholine for Inhalation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- China-Japan Friendship Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This trial was divided into two parts. The first part was the PK bioequivalence study in healthy people, which was designed as a single-dose, randomized, open, four-cycle, two-sequence, fully repeated crossover design, and planned to enroll 20 subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Test preparation：Methylcholine chloroacetate for inhalation | Cholinergic agonists |
| DRUG | Reference preparation：Methylcholine chloroacetate for inhalation（(Provocholin） | Cholinergic agonists |
Timeline
- Start date
- 2024-01-29
- Primary completion
- 2024-02-03
- Completion
- 2024-02-03
- First posted
- 2024-12-12
- Last updated
- 2024-12-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06730620. Inclusion in this directory is not an endorsement.